Increasing the Tempo: Early initiation of SGLT2is for cardiorenal protection

 Chair: Alice Cheng (CAN)

13:30 – 13:35Welcome and introductionAlice Cheng (CAN)
13:35 – 13:45Hitting the right note with impactful goals of careAlice Cheng (CAN)
13:45 – 14:05From the first note: The importance of early interventionPaola Fioretto (ITA)
14:05 – 14:25Reviewing the score: SGLT2is in CKD, T2D and heart failureHiddo Lambers Heerspink (NLD)
14:25 – 14:45Harmonizing diverse patient populationsGian Paolo Fadini (ITA)
14:45 – 15:00Finale: SGLT2is in clinical practice (panel discussion and close)All faculty

 

In Spain, the information displayed is exclusively directed to Health Professionals empowered to prescribe or dispense medicinal products. Please do not distribute in media, supports or communication channels aimed at the general public.
En España, la información mostrada está dirigida exclusivamente a Profesionales Sanitarios facultados para prescribir o dispensar medicamentos. Por favor, no distribuir en medios, soportes o canales de comunicación dirigidos a público general.